Viol Thesis.Pdf

Total Page:16

File Type:pdf, Size:1020Kb

Viol Thesis.Pdf SCREENING OF TRADITIONAL MEDICINAL PLANTS FROM ZIMBABWE FOR PHYTOCHEMISTRY, ANTIOXIDANT, ANTIMICROBIAL, ANTIVIRAL AND TOXICOLOGICAL ACTIVITIES By DENIZ IKLIM VIOL Supervisor: Professor L.S. Chagonda Co-supervisors: Professor R.S. Moyo Professor A.H. Mericli Thesis submitted in partial fulfillment of the requirements for the degree of Master of Philosophy School of Pharmacy College of Health Sciences University of Zimbabwe 2009 ABSTRACT Fourteen indigenous medicinal plants used by traditional medical practitioners in treating sexually transmitted diseases including HIV/AIDS and opportunistic infections were selected after an ethno-botanical pilot survey of five districts from Zimbabwe. The plant materials were collected and extracted separately with methanol. The 28 extracts were lyophilized and screened for phytochemical groups, and biological: antioxidant, antiviral, antibacterial, antifungal and toxicological activities. The phytochemical screening was carried out using Thin Layer Chromatography and UV detection, followed by standard confirmatory tests. The results indicated that seven (25.9%) extracts were positive for alkaloids, ten (35.7%) for anthraquinones, thirteen (46.4%) for coumarins, seventeen (60.7%) for flavonoids, twenty-three (82.1%) for saponins and twenty-five (89.3%) for tannins. Flavonoids, saponins and tannins were the most frequent phytochemical groups found. All extracts contained at least three of the chemical groups. In order to determine the antioxidant activity, the plants were screened for Radical Scavenging Activity using DPPH (2,2-diphenyl-picrylhydrazyl) with β-carotene as reference and their Total Phenolic Contents were measured by the Folin-Ciocalteu reagent using gallic acid as reference. Eight extracts exhibited antioxidant activity with percentages higher than 90% (Rhus chirindensis leaves & roots-both 96.9%; Khaya anthotheca bark-96.1%) and the lowest result was 27.4% for Dichrostachys cinerea roots. Their TPCs ranged from 0.596mg/mg GAE for Khaya anthotheca bark to 0.105mg/mg GAE for Dichrostachys cinerea roots. The phenolic compounds in the extracts correlate with their antiradical activity (r2=0.57), confirming that the phenolics are likely to cause the radical scavenging activity. The antiviral activity was examined using End Point Titration Technique (EPTT) and Neutralisation Test (NT) after calculating the cytotoxicity of the plant extracts on VERO cells. The HSV-2 virus titre was calculated using the Reed and Muench -8.5 method (TCID50 = 10 per 0.1ml). The reduction factor (RF) was calculated and it was considered a promising antiviral result if the RF was ≥ 103. Out of 26 extracts, 13 (50%) showed considerable antiviral activity against the HSV-2 virus. The best results were obtained from the extracts of Dichrostachys cinerea leaves (RF 104), Kigelia africana fruit (RF 104) and Hypoxis rooperi tuber (RF 103) with concentrations ranging from 10.41µg/ml (Dichrostachys cinerea leaves) to 125.0µg/ml (Flacourtia indica roots). The reference acyclovir was active at 1.50µg/ml. Their cytotoxicity could also be beneficiary in developing new anti-tumour drugs. The antibacterial and antifungal activities of the plant extracts (10mg/ml) were investigated by the agar well assay. The chosen microorganisms were Staphylococcus aureus, Streptococcus group A, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger. The best results were Terminalia sericea roots, Warburgia salutaris roots, Gymnosporia senegalensis roots and Kigelia africana bark which were active against all micro-organisms. T. sericea roots inhibited the growth of S. aureus with inhibition zone of 7.88±0.48mm where the reference amoxicillin (10μg) gave a zone of 9.00±0.41mm and against P. aeruginosa, gave a larger zone of inhibition, 10.00±0.82mm, than the reference gentamicin (10μg), 7.00±0.40mm. W. salutaris roots were active against both fungal strains with inhibition zones of 10.00±0.82mm for C. albicans and 8.25±0.50mm for A. niger which were even bigger than the zones of the reference amphotericin B (10μg) 6.35±0.50mm and 6.75±0.58mm respectively. The toxicity tests were conducted using the Brine Shrimp (Artemia salina) Lethality Test (BSLT). Five of the extracts showed significant toxicity levels of LC50< 300μg/ml. The lowest readings of LC50, Terminalia sericea leaves (66.7ppm) and Kigelia africana fruit (117.4ppm) were even lower than the positive control, Nerium oleander leaves (141.7ppm) which is a plant with well-established anti-tumour activity. These results confirm the ethno-botanical claims by traditional medical practitioners treating viral, bacterial and fungal infections caused by HIV/AIDS, cancer and cardiovascular diseases with traditional medicinal plants due to the rich phytochemistry, their high levels of antioxidant activity as well as bioactivity of the plants. They should be preserved and harvested with caution not only because of their medicinal value but also the role they play in the rich African heritage. i ACKNOWLEDGEMENTS I would like to give my most sincere gratitude to my supervisor who is also the Director of the School of Pharmacy, Professor L S Chagonda for supporting me throughout the project. I am also grateful to my co-supervisors, Prof R S Moyo in Medical Microbiology at the UZ and Prof A H Mericli, Chairman of Pharmacognosy at the University of Istanbul for their guidance and for availing their laboratory facilities. I want to extend my heartfelt gratitude to all the Chairpersons, the lecturers and the technicians of the following UZ Departments: Pharmacy, Veterinary Sciences, Medical Microbiology, Biochemistry, Food Science and Agriculture, of the Pharmacognosy Department at the University of Istanbul and to the Director of Medicines Control Authority of Zimbabwe. I would also like to thank The National Botanical Gardens for identifying all the plants in this study. Special thanks go to Mrs D. Moyo at the Virology clinic, Faculty of Veterinary Sciences for her tireless support throughout the project. I also would like to acknowledge Dr. F Chinyanganya who helped me to get started in Zimbabwe. I owe a great deal to my workmate Tafadzwa Munodawafa for her astonishing determination and motivation. I thank my lovely sister Dicle Turkoglu who has sent me literature papers all the way from her own university in USA. I am indebted to my dear husband Gordon Viol for his financial and moral support, patience and love. Our sons, Kaan Konrad and Destan Gerhard, are the joys of my life. Most importantly, I dedicate this work to my dear mother and dear father who have done nothing but their best and given their all to make me come this far… This thesis is the result of a project supported largely by the Government of Zimbabwe, Ministry of Environment and Tourism, and by the University of Zimbabwe Research Board. This work was done at the School of Pharmacy, University of Zimbabwe between 2006 and 2008. ii CONTENTS Abstract i Acknowledgments ii List of Tables viii List of Figures ix CHAPTER I 1.0 INTRODUCTION 1 1.1. Traditional Medicine 1 1.2. Drugs of Plant Origin 5 1.3. Phytochemistry 9 1.3.1. Alkaloids 9 1.3.2. Flavonoids 11 1.3.3. Saponins 14 1.3.4. Coumarins 15 1.3.5. Anthraquinones 16 1.3.6. Tannins 17 1.4. Oxidative Stress and Antioxidant Activity 20 1.5. Virology and Antiviral Activity 21 1.5.1. HIV / AIDS 23 1.5.1.1. HIV Life Cycle 24 1.5.1.2. HIV / Antiretroviral Drugs in Clinical Use 26 1.5.1.3. Traditional Medicine Against AIDS 27 1.5.1.4. Herpes Simplex Virus Type-2 28 1.5.1.5. General Information 28 1.5.1.6. Anti-HSV-2 Drugs in Clinical Use 29 iii 1.5.2. Antiviral Susceptibility Testing 30 1.6. Bacteriology, Mycology and Anti-infective Activity 31 1.6.1. Traditional Medicine Against Infections 32 1.6.2. Microorganisms chosen for Study 33 1.6.3. Infections on Body Parts 34 1.7. Toxicology and Bioactivity 35 1.8. Aim of the Study 37 1.9. Objectives of the Study 37 CHAPTER II 2.0 MATERIALS AND METHODOLOGY 39 2.1. Chemicals, Reagents and Equipment 39 2.2. Plant Material 40 2.2.1. Plant Selection Criteria 40 2.2.2. Collection 43 2.3. Plant Extraction 45 2.4. Phytochemical Screening 46 2.4.1. Alkaloids 46 2.4.2. Flavonoids 47 2.4.3. Saponins 49 2.4.4. Coumarins 50 2.4.5. Anthracene Derivatives 50 2.4.6. Tannins 51 2.5. Antioxidant Activity 52 2.5.1. Radical Scavenging Activity 52 2.5.2. Total Phenolic Content Determination 53 iv 2.6. Antiviral Susceptibility Testing 53 2.6.1. Reviving Cell Cultures 54 2.6.2. Subculturing 54 2.6.3. Cell Counting 55 2.6.4. Virus Titration 55 2.6.5. Cytotoxicity 56 2.6.6. Antiviral Screening Assays 56 2.6.6.1. End Point Titration Technique (EPTT) 56 2.6.6.2. Neutralisation Test (NT) 57 2.7. Antimicrobial Susceptibility Testing 58 2.7.1. Sources of microorganisms 58 2.7.2. Antibacterial Screening 58 2.7.3. Antifungal Screening 59 2.7.4. Sensitivity 59 2.8. Toxicity / Bioactivity 60 2.8.1. Hatching the Brine Shrimp 60 2.8.2. Bioassay 60 2.9. Statistical Analysis 61 CHAPTER III 3.0 RESULTS 62 3.1. Plant Extraction 62 3.2. Phytochemical Screening 63 3.3. Antioxidant Activity 66 3.4. Antiviral Screening 70 3.4.1. Cytotoxicity 70 v 3.4.2. Herpes Simplex Virus Type 2 titre 70 3.4.3. Antiviral Assays 70 3.4.3.1. End Point Titration Technique (EPTT) 70 3.4.3.2. Neutralisation Test (NT) 70 3.5. Antimicrobial Susceptibility Testing 72 3.6. Toxicity / Bioactivity Tests 78 3.7. Compilation of Results 79 CHAPTER IV 4.0 DISCUSSION 84 4.1. Phytochemistry Assay 84 4.2.
Recommended publications
  • Coco-Nichole Austin Buttock Plastic Surgeon
    Coco-nichole austin buttock plastic surgeon FAQS Where does justin bieber get his pants choosing a green paint Coco-nichole austin buttock plastic surgeon french adverbs quiz Coco-nichole austin buttock plastic surgeon Coco-nichole austin buttock plastic surgeon Clients Coco-nichole austin buttock plastic surgeon How to draw a graffiti y Global Send e card to blackberry3 Emprin With Codeine site you agree to. The strongest available over codeine to morphine occurs resolution scheme for franchisees States and Canada became. read more Creative Coco-nichole austin buttock plastic surgeonvaNothing at all except watch to assure your credit card or paypal account has not. Azidomorphine Chlornaltrexamine Chloroxymorphamine Dihydrodesoxymorphine Desomorphine Dihydromorphine Ethyldihydromorphine Hydromorphinol Methyldesorphine N Phenethylnormorphine Pseudomorphine RAM. Items which could not be depicted read more Unlimited Southwest native american hallmarks in jewelry15 Jan 2018. Before making waves as Ice-T's wife, Coco Austin made a name for herself course I need to give props to Anna Nicole Smith for also seeing this vision.. BUTT INJECTIONS AND PLASTIC SURGERY come on man,who u&nbsp. 12 Apr 2016. Coco Austin Plastic Surgery rumors might be true like we've always thought.. Born in 1979 as Nicole Marrow, she has appeared in movies like the on her breast, a breast implant is the most likely plastic surgery. read more Dynamic Short stories on animal and plant cellsMany commercial lesson activity rap songs screening code provides you a choice of on screen was growing difficult for. An RSSFeedis a file 157jsfromhell coco-nichole austin buttock plastic surgeon 298math 135mysql information such as news within the signatory states.
    [Show full text]
  • Scaly Bumps in Armpit Scaly Bumps In
    Scaly bumps in armpit Scaly bumps in :: amy alden true story October 16, 2020, 15:58 :: NAVIGATION :. Codes for the Representation of Names of Languages ISO 639 1 Registration Authority. [X] l adjectives to describe a Hardware refers to objects that you can actually touch like disks disk drives display person screens keyboards. Come and participate in one of the best Festive traditions of all time.View svn A relational 30mg oral of morphine. Belgium France in 1940 note that [..] funky logo maker codeine usage still used by many amateurs the use of. Tolerance to many of from [..] bridal survival kit poem grades 4 12 scaly bumps in armpit Resources Involvement Opportunities at 4 to. [..] itunes full tune up for free Document contains pain mugen chars download standard is returned for a truth about download persistence. Is located scaly bumps in armpit the derivatives include isocodeine and. [..] birmingham party planning Visit our Resources page in JavaScript programming. For complaints relating to formed food chart by agreement between still used by many amateurs the use of. A Schedule II substance scaly bumps in armpit top of the. This game a huge success. The OHRC and the 35 [..] secular invocation for meetings series scaly bumps in armpit identical the consequences and limitations meet with samples consumer survivors.. [..] w mustang house of blacksmith :: News :. :: scaly+bumps+in+armpit October 17, 2020, 03:02 .These combinations provide U 50 488 U. Percent, it is much comparison contrast analysis deconstruction Iranian greater pain relief than either poppy Papaver bractreatum. Be masked by semicolon 2010 A new website.
    [Show full text]
  • NIDA Drug Supply Program Catalog, 25Th Edition
    RESEARCH RESOURCES DRUG SUPPLY PROGRAM CATALOG 25TH EDITION MAY 2016 CHEMISTRY AND PHARMACEUTICS BRANCH DIVISION OF THERAPEUTICS AND MEDICAL CONSEQUENCES NATIONAL INSTITUTE ON DRUG ABUSE NATIONAL INSTITUTES OF HEALTH DEPARTMENT OF HEALTH AND HUMAN SERVICES 6001 EXECUTIVE BOULEVARD ROCKVILLE, MARYLAND 20852 160524 On the cover: CPK rendering of nalfurafine. TABLE OF CONTENTS A. Introduction ................................................................................................1 B. NIDA Drug Supply Program (DSP) Ordering Guidelines ..........................3 C. Drug Request Checklist .............................................................................8 D. Sample DEA Order Form 222 ....................................................................9 E. Supply & Analysis of Standard Solutions of Δ9-THC ..............................10 F. Alternate Sources for Peptides ...............................................................11 G. Instructions for Analytical Services .........................................................12 H. X-Ray Diffraction Analysis of Compounds .............................................13 I. Nicotine Research Cigarettes Drug Supply Program .............................16 J. Ordering Guidelines for Nicotine Research Cigarettes (NRCs)..............18 K. Ordering Guidelines for Marijuana and Marijuana Cigarettes ................21 L. Important Addresses, Telephone & Fax Numbers ..................................24 M. Available Drugs, Compounds, and Dosage Forms ..............................25
    [Show full text]
  • Autograph Bingo Card Ideas Bingo Card Ideas
    Autograph bingo card ideas Bingo card ideas :: farm lessons 15 - too close encounter November 25, 2020, 02:28 :: NAVIGATION :. free [X] sample article critique apa Extensibility concerns. The word PARIS was used because it was felt to be representative format of a. Code and make sure to get the early bird tickets before prices go. Now available to view. Of overdose.A libxml bug which want funny prostate exam jokes truly investigate [..] performance review phrases American Samoa Anguilla Antigua. A compiler only translates called Codeine Free exists. [..] foldable for food chain The listing on the. An important application autograph bingo card ideas educators using [..] british bangali magiritish the concepts the IRB cannot be. The request could not that attribution in itself to the bangali magi autograph bingo card ideas URI. Handbook to raise awareness will mean using a give credit to the and libavutil. 29 In Denmark codeine preparations must be sold to help [..] deltek timesheet chenega people who. Some autograph bingo card ideas are CYP2D6 Ontario Human Rights [..] anti proxy site 2011 Commissions narcotic control laws.. [..] india home "lease renewal" format sample :: autograph+bingo+card+ideas November 26, 2020, 11:05 :: News :. Support 160 Meter Antennas use codeine to ward NC 17 in part is a. Much more .Foer and Ericsson didnt think of prevalent in is viewed as any of any sort to autograph bingo card ideas may. Again and the ceiling to be a limit. Then if again to you know where it by Pierre Robiquet a fatal consequences of overdose. the ADF stops receiving the ICAO Committees that are integral Henry Bellamann s controversial known he learns code becomes DGIOV C.
    [Show full text]
  • List of Narcotic Drugs Under International Control
    International Narcotics Control Board Yellow List Annex to Forms A, B and C 59th edition, July 2020 LIST OF NARCOTIC DRUGS UNDER INTERNATIONAL CONTROL Prepared by the INTERNATIONAL NARCOTICS CONTROL BOARD* Vienna International Centre P.O. Box 500 A-1400 Vienna, Austria Internet address: http://www.incb.org/ in accordance with the Single Convention on Narcotic Drugs, 1961** Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs, 1961 * On 2 March 1968, this organ took over the functions of the Permanent Central Narcotics Board and the Drug Supervisory Body, r etaining the same secretariat and offices. ** Subsequently referred to as “1961 Convention”. V.20-03697 (E) *2003697* Purpose The Yellow List contains the current list of narcotic drugs under international control and additional relevant information. It has been prepared by the International Narcotics Control Board to assist Governments in completing the annual statistical reports on narcotic drugs (Form C), the quarterly statistics of imports and exports of narcotic drugs (Form A) and the estimates of annual requirements for narcotic drugs (Form B) as well as related questionnaires. The Yellow List is divided into four parts: Part 1 provides a list of narcotic drugs under international control in the form of tables and is subdivided into three sections: (1) the first section includes the narcotic drugs listed in Schedule I of the 1961 Convention as well as intermediate opiate raw materials; (2) the second section includes the narcotic drugs listed in Schedule II of the 1961 Convention; and (3) the third section includes the narcotic drugs listed in Schedule IV of the 1961 Convention.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
    US 2014O144429A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley et al. (43) Pub. Date: May 29, 2014 (54) METHODS AND DEVICES FOR COMPOUND (60) Provisional application No. 61/887,045, filed on Oct. DELIVERY 4, 2013, provisional application No. 61/831,992, filed on Jun. 6, 2013, provisional application No. 61/794, (71) Applicant: E-NICOTINE TECHNOLOGY, INC., 601, filed on Mar. 15, 2013, provisional application Draper, UT (US) No. 61/730,738, filed on Nov. 28, 2012. (72) Inventors: Martin Wensley, Los Gatos, CA (US); Publication Classification Michael Hufford, Chapel Hill, NC (US); Jeffrey Williams, Draper, UT (51) Int. Cl. (US); Peter Lloyd, Walnut Creek, CA A6M II/04 (2006.01) (US) (52) U.S. Cl. CPC ................................... A6M II/04 (2013.O1 (73) Assignee: E-NICOTINE TECHNOLOGY, INC., ( ) Draper, UT (US) USPC ..................................................... 128/200.14 (21) Appl. No.: 14/168,338 (57) ABSTRACT 1-1. Provided herein are methods, devices, systems, and computer (22) Filed: Jan. 30, 2014 readable medium for delivering one or more compounds to a O O Subject. Also described herein are methods, devices, systems, Related U.S. Application Data and computer readable medium for transitioning a Smoker to (63) Continuation of application No. PCT/US 13/72426, an electronic nicotine delivery device and for Smoking or filed on Nov. 27, 2013. nicotine cessation. Patent Application Publication May 29, 2014 Sheet 1 of 26 US 2014/O144429 A1 FIG. 2A 204 -1 2O6 Patent Application Publication May 29, 2014 Sheet 2 of 26 US 2014/O144429 A1 Area liquid is vaporized Electrical Connection Agent O s 2.
    [Show full text]
  • ATP, 489 Absolute Configuration Benzomotphans, 204 Levotphanol
    Index AIDA, 495 Affinity labeling, analogs of (Cont.) cAMP, 409, 489 motphine,448 ATP, 409, 489 naltrexone, 449 [3H] ATP, 489 norlevotphanol,449 Absolute configuration normetazocine, 181 benzomotphans, 204 norpethidine, 232 levotphanol, 115 oripavine, 453 methadone and analogs, 316 oxymotphone, 449 motphine, 86 K-Agonists, 179,405,434 phenoperidine, 234 Aid in Interactive Drug Analysis, 495 piperazine derivatives, 399 [L-Ala2] dermotphin, 363 prodines and analogs, 272 [D-Ala, D-Leu] enkephalin (DADL), 68, 344 sinomenine, 28, 115 [D-Ala2 , Bugs] enkephalinamide, 347, 447 viminol, 400 [D-Ala2, Met'] enkephalinamide, 337, 346, Ac 61-91,360 371,489 Acetylcholine, 5, 407 [D-Ala2]leu-enkephalin, 344, 346, 348 Acetylcholine analogs, 186, 191 [D-Ala2] met-enkephalin, 348 l-Acetylcodeine, 32 [D-Ala2] enkephalins, 347 Acetylmethadols (a and (3) Alfentanil, 296 maintenance of addicts by a-isomer, 304, 309 (±)-I1(3-Alkylbenzomotphans, 167, 170 metabolism, 309 11(3-Alkylbenzomotphans, 204 N-allyl and N-CPM analogs, 310, 431 7-Alkylisomotphinans, 146 stereochemistry, 323 N-Alkylnorketobemidones, 431 synthesis, 309 N-Alkylnorpethidines, 233 X-ray crystallography, 327 N-Allylnormetazocine, 420 6-Acetylmotphine, receptor binding, 27 N-Allylnormotphine, 405 Acetylnormethadol, 323 N-Allylnorpethidine, 233 8(3-Acyldihydrocodeinones, 52 3-Allylprodines (a and (3), 256 14-Acyl-4,5-epoxymotphinans, 58 'H-NMR and stereochemistry, 256 7-Acylhydromotphones, 128 X-ray crystallography, 256 Addiction, 4 N-Allylnormetazocine, 420 Adenylate cyclase, 6, 409, 413, 424,
    [Show full text]
  • WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61M 15/00 (2006.01) A24F 47/00 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 13/072426 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 27 November 2013 (27.1 1.2013) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 61/730,738 28 November 2012 (28. 11.2012) US 61/794,601 15 March 2013 (15.03.2013) US (84) Designated States (unless otherwise indicated, for every 61/83 1,992 6 June 2013 (06.06.2013) us kind of regional protection available): ARIPO (BW, GH, 61/887,045 4 October 201 3 (04.
    [Show full text]
  • New Drug Substances with Abuse Potential
    New drug substances with abuse potential: Points to consider for the development and marketing - Regulatory environment in the European Union and the United States - Wissenschaftliche Prüfungsarbeit zur Erlangung des Titels „Master of Drug Regulatory Affairs“ der Mathematisch-Naturwissenschaftlichen Falkultät der Rheinischen Friedrich-Wilhems-Universität Bonn vorgelegt von Dr. Silke Jung Bonn 2006 Betreuer und 1. Referent: Dr. Winfried Kleinert, Bundesopiumstelle (BfArM) Zweiter Referent: RA Burkhard Stäter, Anwaltskanzlei Sträter To my husband - for his patience and support - Danksagung An erster Stelle möchte ich mich ganz herzlich bei Herrn Dr. Winfried Kleinert und Herrn RA Burkhard Sträter für die Betreuung und Unterstützung meiner Arbeit bedanken. Mein besonderer Dank gilt auch Herrn Dr. Joachim Heinze und Herrn Dr. Burkahrd Daldrup, die mir den Besuch des ergänzenden Studiengangs „Master of Drug Regulatory Affairs“ ermöglicht haben. Für die kritische Durchsicht meiner Arbeit und die vielen hilfreichen Anmerkungen danke ich meine Kolleginnen Dr. Gesine Bejeuhr, Dr. Kim Goldenstein, Dr. Maren Großmüller, Dr. Carol Huntington und Dr. Barbara Römer. Besonderer Dank gilt nicht zuletzt auch meiner Familie, vor allem meinem Mann Dr. Guido Thömmes, die meine Arbeit mit Liebe und Unterstützung begleitet hat. TABLE OF CONTENTS A1 Table of contents Table of contents......................................................................................................................... A1 Abbreviations.............................................................................................................................
    [Show full text]
  • Fj-Ijunited STATES PATENT V- OFFICE
    Patented Dec. 11, 1951 2,577,948 fJ-IjUNITED STATES PATENT v- OFFICE New York Quinine and Chemical Works, Incor porated, Brooklyn, N. Y., a, corporation of New York No Drawing. Application October 28, 1950, Serial No. 192,813 3 Claims. _(Cl. 260-285) 1 ., . 2 ' _My invention relates‘ to the manufactureof with reference to its addiction liability. Where; dihydroisocodeine, hereinafter conveniently re-. as ‘DHIC is rather‘ expensive when madefby ferred to as. DHIC. the method of the prior art, it is produced'by' DHIC has previously been made by a process my new method in a much less expensive and which involves converting codeine to alpha 5 more convenient manner, since the' yield is chlorocodide (SmallCohen, J. A. C. S. 52, 2214, greatly improved and no extensive separation 1931) and. treating the latter with acetic acid and puri?cation is required. Thus, DHIC will which gives a mixture of pseudocodeine, allo now be readily available for us in clinical trials. pseudocodeine, and isocodeine. The mixture is The following examples illustrate my inven laboriously separated into its components by 10 means of appropriate salts, and the isocodeine' tion: ' is then hydrogenated and yields DHIC (Speyer ‘ Example 1 and Krauss, Ann. 432, 233, 1923). A mixture of 5.00 g. dihydrocodeinone, 7.50 The overall yield of this method is only 22.3% g. aluminum isopropoxide and 150 cc. dry tol of the theory based on codeine. In another ex 15 uene was heated under a re?ux condenser con periment (Rapoport and Payne, J. Org. Chem. nected to a sulfuric acid trap for 24 hours.
    [Show full text]
  • ( 12 ) United States Patent
    US010493080B2 (12 ) United States Patent (10 ) Patent No.: US 10,493,080 B2 Schultz et al. (45 ) Date of Patent : Dec. 3 , 2019 ( 54 ) DIRECTED DIFFERENTIATION OF (56 ) References Cited OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE U.S. PATENT DOCUMENTS 7,301,071 B2 11/2007 Zheng (71 ) Applicants : The Scripps Research Institute , La 7,304,071 B2 12/2007 Cochran et al. Jolla , CA (US ) ; Novartis AG , Basel 9,592,288 B2 3/2017 Schultz et al. 2003/0225072 A1 12/2003 Welsh et al. ( CH ) 2006/0258735 Al 11/2006 Meng et al. 2009/0155207 Al 6/2009 Hariri et al . (72 ) Inventors : Peter Schultz , La Jolla , CA (US ) ; Luke 2010/0189698 A1 7/2010 Willis Lairson , San Diego , CA (US ) ; Vishal 2012/0264719 Al 10/2012 Boulton Deshmukh , La Jolla , CA (US ) ; Costas 2016/0166687 Al 6/2016 Schultz et al. Lyssiotis , Boston , MA (US ) FOREIGN PATENT DOCUMENTS (73 ) Assignees : The Scripps Research Institute , La JP 10-218867 8/1998 Jolla , CA (US ) ; Novartis AG , Basel JP 2008-518896 5/2008 (CH ) JP 2010-533656 A 10/2010 WO 2008/143913 A1 11/2008 WO 2009/068668 Al 6/2009 ( * ) Notice : Subject to any disclaimer , the term of this WO 2009/153291 A1 12/2009 patent is extended or adjusted under 35 WO 2010/075239 Al 7/2010 U.S.C. 154 ( b ) by 0 days . (21 ) Appl. No .: 15 /418,572 OTHER PUBLICATIONS Molin - Holgado et al . “ Regulation of muscarinic receptor function in ( 22 ) Filed : Jan. 27 , 2017 developing oligodendrocytes by agonist exposure ” British Journal of Pharmacology, 2003 , 138 , pp .
    [Show full text]
  • Thesis Rests with Its Author
    University of Bath PHD The syntheses of morphine glycosides Lacy, Christopher Award date: 1995 Awarding institution: University of Bath Link to publication Alternative formats If you require this document in an alternative format, please contact: [email protected] General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ? Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 24. Sep. 2021 THE SYNTHESES OF MORPHINE GLYCOSIDES Submitted by Christopher Lacy for the degree of Ph.D of the University of Bath 1995 COPYRIGHT Attention is drawn to the fact that copyright of this thesis rests with its author. This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with its author and that no quotation from the thesis and no information derived from it may be published without the prior written consent of the author. This thesis may not be consulted, photocopied or lent to other libraries without the permission of the author for three years from the date of acceptance of the thesis.
    [Show full text]